Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Poland
Clinical trial register · Poland

Clinical Trials in Poland

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2721 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:18 UTC
2721
Studies in scope
all four open statuses
1385
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Warsaw 31 Krakow 30 Wroclaw 29 Katowice 24 Poznan 21

Trials in this register

56 of 2721 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Pfizer
Phase 3
920
Milówka, Bialystok, Bydgoszcz, Dziekanów Leśny, Katowice, Krakow, Tarnów, Trzebnica
2026-09-22
Recruiting
Pfizer
Phase 2
120
Wroclaw
2026-06-30
Recruiting
Pfizer
Phase 3
1,200
Milówka, Dziekanów Leśny, Krakow, Tarnów, Trzebnica
2026-06-15
Recruiting
Pfizer
Phase 3
954
Bialystok, Gdansk, Lublin, Poznan, Wroclaw
2026-06-10
Recruiting
Pfizer
Phase 2
24
Warsaw, Katowice
2026-05-28
Recruiting
Pfizer
Phase 3
2,400
Krakow, Milówka, Bydgoszcz, Dziekanów Leśny, Poznan, Torun, Trzebnica, Wroclaw
2026-05-04
Active, closed
Pfizer
Phase 3
1,078
Lodz, Bialystok, Bydgoszcz, Chojnice, Częstochowa, Gdansk, Gdynia, Katowice
2026-02-24
Recruiting
Pfizer
Phase 2/3
1,156
Katowice, Krakow, Tarnów, Warsaw, Wroclaw, Ostrowiec Świętokrzyski
2026-02-11
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Radom, Katowice, Kielce, Lodz, Lublin, Opole, Wroclaw, Tomaszów Mazowiecki
2026-01-06
Active, closed
Pfizer
Phase 3
3,578
Bialystok, Bydgoszcz, Chojnice, Częstochowa, Gdansk, Gdynia, Katowice, Krakow
2025-12-19
Recruiting
Pfizer
Phase 3
800
Katowice, Koszalin, Krakow, Opole, Poznan
2025-12-11
Recruiting
Pfizer
Phase 3
450
Krakow, Lublin, Warsaw, Chorzów, Lodz, Ostrowiec Świętokrzyski
2025-12-02
Recruiting
Pfizer
Phase 2
165
Krakow, Szczecin, Gdansk, Katowice, Kielce
2025-11-20
Active, closed
Pfizer
Phase 2
128
Wroclaw, Gdansk, Ostrowiec Świętokrzyski, Sosnowiec, Szczecin, Warsaw
2025-11-13
Recruiting
Pfizer
Phase 2
200
Warsaw, Chorzów, Gdansk, Lublin, Tarnów, Wroclaw
2025-10-30
Recruiting
Pfizer
Phase 2/3
982
Warsaw, Olsztyn, Koszalin, Poznan, Tomaszów Mazowiecki
2025-10-03
Recruiting
Pfizer
Phase 3
680
Lublin, Poznan, Tomaszów Mazowiecki, Lodz
2025-09-29
Recruiting
Pfizer
Phase 3
1,000
Poznan, Wroclaw, Szczecin, Koszalin, Krakow, Lublin, Rzeszów
2025-09-28
Recruiting
Pfizer
Phase 3
140
Krakow, Wroclaw, Lublin, Warsaw, Bialystok, Katowice, Rzeszów, Lodz
2025-09-10
Active, closed
Pfizer
Phase 3
208
Krakow, Wroclaw, Lublin, Warsaw, Bialystok, Katowice, Ossy, Rzeszów
2025-07-31
Active, closed
Pfizer
Phase 3
151
Krakow, Lublin, Warsaw, Chorzów, Katowice, Lodz, Ostrowiec Świętokrzyski
2025-07-24
Recruiting
Pfizer
Phase 3
714
Poznan, Lublin, Warsaw, Gdansk, Gliwice, Lodz
2025-07-23
Recruiting
Pfizer
Phase 2
620
Poznan, Bydgoszcz, Torun, Puławy, Sopot, Katowice
2025-06-19
Recruiting
Pfizer
Phase 2
252
Poznan, Krakow, Tarnów, Wroclaw, Bychawa, Sosnowiec
2025-05-20
Recruiting
Pfizer
Phase 3
674
Poznan, Krakow, Wroclaw, Lublin, Nowa Sól, Warsaw, Katowice, Sosnowiec
2025-04-01
Recruiting
Pfizer
Phase 3
723
Krakow, Oświęcim, Wroclaw, Lublin, Warsaw, Katowice
2025-03-11
Recruiting
Pfizer
Phase 3
211
Warsaw, Bialystok
2025-01-22
Active, closed
Pfizer
Phase 3
636
Bydgoszcz, Krakow, Wroclaw, Lublin, Warsaw
2024-11-15
Recruiting
Pfizer
Phase 1
119
Katowice, Szczecin, Lodz
2024-11-05
Active, closed
Pfizer
Phase 3
900
Krakow, Wroclaw, Lublin, Warsaw, Koszalin, Opole, Piotrkow Trybunalski
2024-10-22
Active, closed
Pfizer
Phase 3
609
Grudziądz, Torun, Krakow, Wroclaw, Opole, Koszalin
2024-10-21
Active, closed
Pfizer
Phase 3
394
Osielsko, Warsaw, Szczecin, Lodz, Ostrowiec Świętokrzyski
2024-01-19
Active, closed
Pfizer
Phase 3
1,571
Bydgoszcz, Krakow, Warsaw, Bialystok, Katowice, Szczecin, Lodz
2023-11-08
Active, closed
Pfizer
Phase 2
507
Poznan, Krakow, Wroclaw, Katowice, Ostrowiec Świętokrzyski
2023-08-22
Active, closed
Pfizer
Phase 3
624
Krakow, Warsaw, Gdansk, Lodz
2023-03-03
Recruiting
Pfizer
Phase 2
36
Warsaw, Katowice, Krakow, Szczecin, Wroclaw
2022-12-16
Active, closed
Pfizer
Phase 3
854
Skórzewo, Katowice, Gdansk, Poznan, Warsaw, Wroclaw
2022-03-25
Recruiting
Pfizer
Phase 3
640
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Katowice
2022-02-28
Recruiting
Pfizer
Phase 3
893
Bydgoszcz, Gdansk, Katowice, Poznan, Skorzewo, Warsaw, Wroclaw
2021-10-04
Active, closed
Pfizer
Phase 3
77
Warsaw
2021-09-29
Active, closed
Pfizer
Phase 3
118
Warsaw, Lodz, Rzeszów, Wroclaw
2021-08-12
Recruiting
Pfizer
Phase 3
600
Katowice, Krakow, Poznan, Wroclaw
2021-04-28
Recruiting
Pfizer
Phase 3
2,100
Wroclaw, Katowice, Krakow, Poznan, Szczecin
2021-01-15
Active, closed
Pfizer
Phase 3
841
Konin, Brzozów, Bytom, Gdansk
2020-12-21
Active, closed
Pfizer
Phase 3
1,068
Gliwice, Grudziądz, Mysłowice, Piotrkow Trybunalski, Poznan, Skierniewice, Warsaw, Wroclaw
2019-12-30
Active, closed
Pfizer
Phase 3
896
Poznan, Wroclaw, Będzin, Bialystok, Gdansk, Gdynia, Jelenia Góra, Lodz
2019-09-05
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
Pfizer
Phase 1
453
Bydgoszcz, Koszalin, Krakow, Rzeszów, Warsaw
2018-04-17
Active, closed
Pfizer
Phase 3
1,054
Brzozów, Gdynia, Konin, Otwock, Warsaw
2017-12-18
Active, closed
Pfizer
Phase 3
296
Gdansk, Poznan, Szczecin, Warsaw
2017-04-27
Active, closed
Pfizer
Phase 3
1,068
Wroclaw, Torun, Gdansk, Słupsk
2014-12-17
Rows per page Showing 1–56 of 56
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-poland

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,721 studies in total at the last sync on 19 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 56 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Poland?

32 of the 56 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 24 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 56 studies
PhaseStudiesRecruitingShare
Phase 3422175%
Phase 210717.9%
Phase 1223.6%
Phase 2/3223.6%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Pfizer5632

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Atopic Dermatitis (4) Multiple Myeloma (3) Ulcerative Colitis (3) Carcinoma, Non-Small-Cell Lung (3) Hormone Sensitive Prostate Cancer (2) Prostate Cancer (2) Cancer of the Prostate (2) Pneumococcal Disease (2) Obesity (2) Overweight and/or Obesity (2) Overweight (2) Non-Small Cell Lung Cancer (2) Carcinoma, Non-Small-Cell Lung (NSCLC) (2) Severe Alopecia Areata (2) Migraine (2)
→

Browse trials by site location

Warsaw (31) Krakow (30) Wroclaw (29) Katowice (24) Poznan (21) Lublin (15) Gdansk (15) Lodz (14) Bialystok (11) Bydgoszcz (10) Szczecin (9) Koszalin (7) Ostrowiec Świętokrzyski (6) Rzeszów (5) Opole (5)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.